SCHEMBL4758533

SCHEMBL4758533

NC1=C2C=CC=CC2NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17306807 0.71 NOS2 (0.39)
SCHEMBL6233876 0.64
SCHEMBL8854822 0.63 BACE1 (0.37)
Hydrochloric Acid SCHEMBL7013830 0.63
SCHEMBL1979240 0.61
SCHEMBL424369 0.61
SCHEMBL20967802 0.61
SCHEMBL21215341 0.57
SCHEMBL9712194 0.56
SCHEMBL2117309 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957480-A1 SUBSTITUTED OXINDOL-DERIVATIVES, MEDICAMENTS CONTAINING SAID DERIVATIVES AND USE THEREOF Abbott GmbH & Co. KG (DE) 2008-08-20 EP disclosed
EP-1861392-A2 SUBSTITUTED OXINDOL DERIVATIVES, DRUGS CONTAINING SAID DERIVATIVES AND THE USE THEREOF Abbott GmbH & Co. KG (DE) 2007-12-05 EP disclosed
WO-2007063123-A1 SUBSTITUTED OXINDOL-DERIVATIVES, MEDICAMENTS CONTAINING SAID DERIVATIVES AND USE THEREOF ABBOTT GMBH & CO. KG (DE) 2007-06-07 WO disclosed
WO-2006100082-A2 SUBSTITUTED OXINDOL DERIVATIVES, DRUGS CONTAINING SAID DERIVATIVES AND THE USE THEREOF ABBOTT GMBH & CO. KG (DE) 2006-09-28 WO disclosed